Amikacin is a veterinary antibiotic. Concentration-dependent aminoglycoside with excellent Gram-negative (incl. Indications include resistant Gram-negative sepsis / pyelonephritis; pseudomonas otitis and soft-tissue infection; foal Gram-negative sepsis / septic arthritis. This monograph lists 16 reference doses for dogs, cats, horses, birds, rabbits and ferrets and 9 more species, each with route, frequency and source.
10–30 mg/kg IV q24h — check the species tables for the indication
Routes
IV, IM, SC
Last reviewed
1 October 2026
Indications
Resistant Gram-negative sepsis / pyelonephritis
Pseudomonas otitis and soft-tissue infection
Foal Gram-negative sepsis / septic arthritis
Reptile and avian Gram-negative infections
Amikacin dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
Amikacin doses for dogs
Indication
Dose
Route
Frequency
Duration
Resistant Gram-negative infection
15–30 mg/kg
IV
q24h
—
Resistant Gram-negative infection: Papich 5e: 15 mg/kg q24h IV, IM or SC. Plumb’s p.64: 15 mg/kg IV or 20 mg/kg SC/IM q24h — Greyhounds and possibly other sighthounds 10 mg/kg IV or 15 mg/kg SC/IM (KuKanich 2008); sepsis 20 mg/kg IV once daily; empiric 15–30 mg/kg. Neutropenic patients may need the daily dose divided q8h. Give IV over 20–30 min; monitor renal function and urine sediment.
Cats
Amikacin doses for cats
Indication
Dose
Route
Frequency
Duration
Resistant Gram-negative infection
10–15 mg/kg
IV
q24h
—
Resistant Gram-negative infection: Papich 5e: 10 mg/kg q24h IV, IM or SC. Plumb’s p.64: empiric 10–15 mg/kg (Autran de Morais 2009); 15 mg/kg once daily (Trepanier 1999); sepsis 20 mg/kg IV once daily (Hardie 2000). Nephrotoxic — hydrate; avoid with other nephrotoxins.
Horses
Amikacin doses for horses
Indication
Dose
Route
Frequency
Duration
Adult susceptible infection
10 mg/kg
IV
q24h
—
Foal sepsis
20–25 mg/kg
IV
q24h
—
Adult susceptible infection: Papich 5e and Plumb’s p.64 (Geor & Papich 2003): adults 10 mg/kg IV or IM once daily. Intrauterine: 2 g in 200 mL sterile saline daily for 3 days (label). Regional limb perfusion 500 mg–2 g (Plumb’s).
Foal sepsis: Papich 5e: foals 20 mg/kg q24h IV. Plumb’s p.64: neonatal foals 21 mg/kg IV once daily (Magdesian 2004) or initially 25 mg/kg IV once daily with therapeutic drug monitoring (Bucki 2004); foals under 30 days 20–25 mg/kg IV or IM q24h (Geor & Papich 2003).
Birds
Amikacin doses for birds
Indication
Dose
Route
Frequency
Duration
Gram-negative infection (companion birds)
15–20 mg/kg
IM
q12–24h
—
Gram-negative infection (companion birds): Plumb’s p.64: 15 mg/kg IM or SC q12h (Hoeffer 1995); gentamicin-resistant Gram-negatives 15–20 mg/kg IM once or twice daily (Clubb 1986); macaw sinusitis 40 mg/kg IM once or twice daily with sinus flushing. Keep the bird hydrated; nephrotoxic. (The previous 2.5–5 mg/kg was well below these doses.)
Rabbits
Amikacin doses for rabbits
Indication
Dose
Route
Frequency
Duration
Resistant Gram-negative infection
5–16 mg/kg
SC
q24h
—
Resistant Gram-negative infection: Plumb’s p.64 (Ivey & Morrisey 2000): rabbits 8–16 mg/kg total daily dose SC, IM or IV (may be divided q8–24h — once daily is more effective and less toxic); if IV, dilute in 4 mL/kg saline over 20 min. Morrisey & Carpenter: 5–10 mg/kg divided q8–24h. Nephrotoxic — keep well hydrated.
Gram-negative / respiratory infection (snakes): Plumb’s p.64: snakes 5 mg/kg IM (forebody) loading dose, then 2.5 mg/kg q72h for 7–9 treatments (Gauvin 1993; Mader 1985) — house at the high end of the preferred temperature range; lower dose for Python curtus. Turtles with shell disease 10 mg/kg daily (water turtles) or every other day (tortoises) for 7–10 days. Hydrate; monitor uric acid.
Chinchillas
Amikacin doses for chinchillas
Indication
Dose
Route
Frequency
Duration
Resistant Gram-negative infection
10–15 mg/kg
SC
q8–24h
—
Resistant Gram-negative infection: Plumb’s p.64: 10–15 mg/kg SC, IM or IV divided q8–24h (Morrisey & Carpenter 2004); 2–5 mg/kg SC or IM q8–12h (Hayes 2000).
Nephrotoxicity — proximal tubular damage (often reversible if caught early)
Ototoxicity — vestibular and cochlear (may be irreversible)
Neuromuscular blockade (rare, under anaesthesia)
Drug interactions
Beta-lactams (penicillins, cephalosporins): synergistic against some organisms, but physically inactivate aminoglycosides in vitro — NEVER mix in the same syringe or line; inactivation also occurs in vivo in renal failure
Cephalosporins: possible additive nephrotoxicity, though Plumb's notes this was only well documented with cephaloridine and cephalothin (both withdrawn)
Loop diuretics (furosemide, torsemide) and osmotic diuretics (mannitol): increase nephrotoxic and ototoxic potential
NSAIDs: additive nephrotoxic risk — many clinicians avoid the combination
Trough levels < 2–5 µg/mL to confirm clearance before the next dose where assay is available
Hydration status — never dose a dehydrated patient
Vestibular signs (head tilt, nystagmus)
Toxicity and overdose
Plumb's p.63: for inadvertent overdose, haemodialysis is very effective at reducing serum levels but is rarely practical in veterinary patients; peritoneal dialysis works but far less well. Complexing the drug with carbenicillin or ticarcillin is reportedly nearly as effective as haemodialysis, though amikacin is less susceptible to this effect than gentamicin or tobramycin, so the reduction achieved will be smaller. The clinically important toxicities are cumulative rather than acute: nephrotoxicity (proximal tubular), ototoxicity (vestibular and cochlear, often irreversible) and neuromuscular blockade. Risk rises sharply with pre-existing renal disease, neonatal or geriatric age, fever, sepsis and dehydration. NEVER dose a dehydrated patient.
Clinical pearls
Once-daily dosing is both more effective (peak-dependent killing) and less nephrotoxic than divided dosing
Always pair with IV fluid support and recheck renal values — discontinue at the first sign of tubular casts
Synergistic with beta-lactams against Enterococcus / Pseudomonas — give in separate syringes
Mechanism of action
Aminoglycoside. Plumb's p.63: binds irreversibly to the 30S ribosomal subunit, inhibiting protein synthesis — bactericidal and CONCENTRATION-dependent (hence once-daily dosing, which maximises peak:MIC while allowing a drug-free trough for tubular recovery). Spectrum covers most E. coli, Klebsiella, Proteus, Pseudomonas, Salmonella, Enterobacter, Serratia, Shigella, Mycoplasma and Staphylococcus. Crucially, several Pseudomonas aeruginosa, Proteus and Serratia strains that are RESISTANT to gentamicin remain susceptible to amikacin — this is its main niche. Activity is enhanced in an alkaline environment and reduced in acidic or anaerobic conditions (e.g. abscess cavities).
Formulations and products
Amikacin sulfate 50 mg/mL injection
Amikacin sulfate 250 mg/mL injection
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Reference doses for Amikacin in dogs: 15–30 mg/kg IV q24h (Resistant Gram-negative infection). Confirm against the label and the patient before use.
What is the dose of Amikacin for cats?
Reference doses for Amikacin in cats: 10–15 mg/kg IV q24h (Resistant Gram-negative infection). Confirm against the label and the patient before use.
What is the dose of Amikacin for horses?
Reference doses for Amikacin in horses: 10 mg/kg IV q24h (Adult susceptible infection); 20–25 mg/kg IV q24h (Foal sepsis). Confirm against the label and the patient before use.